Latest market price
20.47
-0.12-0.58%
ACADQT49Acadia Pharmaceuticals Inc.·NASDAQ
20.47-0.58%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 30, 20264Statement of changes in beneficial ownership
Oct 23, 20268-KCurrent report
Sep 24, 20268-KCurrent report
Sep 11, 20268-KCurrent report
Aug 07, 20264Statement of changes in beneficial ownership
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 05, 202610-QQuarterly report
Aug 05, 2026144Notice of proposed sale of restricted securities
Aug 04, 20268-KCurrent report
Jul 31, 20264Statement of changes in beneficial ownership
Jun 29, 20264Statement of changes in beneficial ownership
Jun 26, 2026144Notice of proposed sale of restricted securities
Jun 10, 2026S-8Registration of employee benefit securities
Jun 02, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
Jun 01, 20264Statement of changes in beneficial ownership
May 29, 20268-KCurrent report
May 27, 20264Statement of changes in beneficial ownership
May 26, 2026144Notice of proposed sale of restricted securities
May 07, 202610-QQuarterly report
May 06, 20268-KCurrent report